Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical or pending clinical studies for brain and other cancers. The company is headquartered in Jerusalem, Israel.
Israeli Market Performance
7D7 Days: -1.7%
3M3 Months: 18.6%
1Y1 Year: 67.6%
YTDYear to Date: 27.4%
Over the last 7 days, the market has dropped 1.7%, driven by losses in the Financials and Real Estate sectors of 1.8% and 2.9%, respectively. As for the longer term, the market has actually risen by 68% in the last year. As for the next few years, earnings are expected to grow by 16% per annum. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.